It is well known that hyperthermia (HY), which is used for the treatment of
cancer; depresses natural cell-mediated immunity in vitro. Experiments wer
e performed to confirm the inhibitory effect of HY (42 degrees C for I hour
;) on natural killer (NK) activity and to evaluate the influence of HY on t
he generation and cytotoxic activity of interleukin-2 (IL-2)-activated NK c
ells. Additional experiments were also carried out to evaluate the effect o
f a simultaneous exposure of effector and target cells to MY: The results s
howed that HY profoundly reduced the lytic activity of NK cells and demonst
rated that this inhibition was transient and not due to an apoptosis-induce
d reduction of the number of effector cells. Moreover; the exposure of mono
nuclear mononuclear cells to KY before IL-2 stimulation did not affect the
generation of IL-2-activated NK cells, whereas, the hyperthermic treatment
of IL-2-activated NK cells produced a mal ked reduction of their cytotoxic
activity. The results also showed that the simultaneous exposure of effecto
r and target cells to HI: during the cytotoxicity assay, produced a marked
reduction of lytic activity of NK and IL-2-activated NK cells, and that thi
s impairment was specific for effector. cells. In this context, heat-exposu
re of target cells alone, did not substantially modify their susceptibility
to lysis induced by either NK ol IL-2-activated NK cells. These results ad
d further evidence of MY-induced inhibition of natural cell-mediated immuni
ty, and suggest that, in the course of therapeutic HY, immune response coul
d be significantly altered.